Cargando…

Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients

BACKGROUND: The Bladder Cancer Index (BCI) and Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys) were developed to measure disease-specific health-related quality of life (HRQOL) in bladder cancer patients and patients treated with radical cystectomy, respectively. Both patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michels, Charlotte T. J., Wijburg, Carl J., Abma, Inger L., Witjes, J. Alfred, Grutters, Janneke P. C., Rovers, Maroeska M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745039/ https://www.ncbi.nlm.nih.gov/pubmed/31522328 http://dx.doi.org/10.1186/s41687-019-0149-7

Ejemplares similares

Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study
por: Wijburg, C. J., et al.
Publicado: (2018)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

Appraising convergent validity of patient-reported outcome measures in systematic reviews: constructing hypotheses and interpreting outcomes
por: Abma, Inger L., et al.
Publicado: (2016)

Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients
por: Degboe, Arnold, et al.
Publicado: (2019)

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
por: Kiemeney, L. A., et al.
Publicado: (1993)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)

Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study
por: Scholte, Mirre, et al.
Publicado: (2020)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

The development of a patient-reported outcome measure for patients with obstructive sleep apnea: the Patient-Reported Apnea Questionnaire (PRAQ)
por: Abma, Inger L., et al.
Publicado: (2017)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

Topic issue on new treatments in bladder cancer
por: Witjes, J. A.
Publicado: (2009)

Instrument completion and validation of the patient-reported apnea questionnaire (PRAQ)
por: Abma, Inger L., et al.
Publicado: (2018)

Does the Patient-Reported Apnea Questionnaire (PRAQ) increase patient-centredness in the daily practice of sleep centres? a mixed-methods study
por: Abma, Inger L, et al.
Publicado: (2019)

The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life
por: de Goeij, Liesbeth, et al.
Publicado: (2019)

The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective
por: van Asten, Freekje, et al.
Publicado: (2018)

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer
por: Ripping, T. M., et al.
Publicado: (2022)

Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci
por: Grotenhuis, Anne J., et al.
Publicado: (2014)

Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
por: Lammers, Rianne J. M., et al.
Publicado: (2015)

Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009)

Is Schistosomiasis a Risk Factor for Bladder Cancer? Evidence-Based Facts
por: Jalloh, Mohamed, et al.
Publicado: (2020)

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
por: Beije, N., et al.
Publicado: (2022)

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
por: Kamat, Ashish M., et al.
Publicado: (2016)

Identification of long non-coding RNAs that stimulate cell survival in bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2017)

Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model
por: Falke, J., et al.
Publicado: (2018)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
por: Brummelhuis, Iris S. G., et al.
Publicado: (2021)

Adherence to the WCRF/AICR Cancer Prevention Recommendations and Risk of Recurrence in Non-muscle Invasive Bladder Cancer
por: van Zutphen, Moniek, et al.
Publicado: (2022)

Profiling the Bladder Microbiota in Patients With Bladder Cancer
por: Parra-Grande, Mónica, et al.
Publicado: (2022)

The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
por: van der Heijden, Antoine G., et al.
Publicado: (2007)

Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling
por: Grutters, Janneke P.C., et al.
Publicado: (2019)

The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis
por: Wenjuan, Cao, et al.
Publicado: (2016)

Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer
por: Karsh, Lawrence, et al.
Publicado: (2018)

Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020)

Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response
por: Grotenhuis, Anne J., et al.
Publicado: (2016)

Exploratory, Participatory and Iterative Assessment of Value: A Response to Recent Commentaries
por: Grutters, Janneke P.C., et al.
Publicado: (2020)

Towards early and broad evaluation of innovative surgical devices: integrating evidence synthesis, stakeholder involvement, and health economic modeling into the clinical research stages of the IDEAL framework
por: Scholte, Mirre, et al.
Publicado: (2022)

The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres – results of CysTiming Poland study
por: Poletajew, Sławomir, et al.
Publicado: (2014)

Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent
por: van Hoogstraten, Lisa M.C., et al.
Publicado: (2022)

LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2018)

Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis
por: Beeren, Ivy, et al.
Publicado: (2022)

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
por: van Hoogstraten, Lisa M. C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2ptq6tsof0900378h8i0rb27q